par Jilek, Samantha;Jaquiéry, Emilie;Hirsch, Hans H;Lysandropoulos, Andreas ;Canales, Mathieu;Guignard, Laurence;Schluep, Myriam;Pantaleo, Giuseppe;Du Pasquier, Renaud A
Référence Lancet neurology, 9, 3, page (264-272)
Publication Publié, 2010-03
Référence Lancet neurology, 9, 3, page (264-272)
Publication Publié, 2010-03
Article révisé par les pairs
Résumé : | Natalizumab is used to prevent relapses and progression of disability in patients with multiple sclerosis but has been associated with progressive multifocal leukoencephalopathy (PML). We aimed to better understand the associations between JC virus, which causes PML, and natalizumab treatment. |